• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管腺癌体外模型的标准化及其在模型药物测试中的适用性。

Standardization of esophageal adenocarcinoma in vitro model and its applicability for model drug testing.

机构信息

Faculty of Medicine, Institute of Cell Biology, University of Ljubljana, Vrazov trg 2, 1000, Ljubljana, Slovenia.

Faculty of Pharmacy, Chair of Biopharmaceutics and Pharmacokinetics, University of Ljubljana, Aškerčeva c. 7, 1000, Ljubljana, Slovenia.

出版信息

Sci Rep. 2021 Mar 23;11(1):6664. doi: 10.1038/s41598-021-85530-w.

DOI:10.1038/s41598-021-85530-w
PMID:33758229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7988140/
Abstract

FLO-1 cell line represents an important tool in esophageal adenocarcinoma (EAC) research as a verified and authentic cell line to study the disease pathophysiology and antitumor drug screenings. Since in vitro characteristics of cells depend on the microenvironment and culturing conditions, we performed a thorough characterization of the FLO-1 cell line under different culturing conditions with the aim of (1) examining the effect of serum-free growth medium and air-liquid interface (A-L) culturing, which better reflect physiological conditions in vivo and (2) investigating the differentiation potential of FLO-1 cells to mimic the properties of the in vivo esophageal epithelium. Our study shows that the composition of the media influenced the morphological, ultrastructural and molecular characteristics of FLO-1 cells, such as the expression of junctional proteins. Importantly, FLO-1 cells formed spheres at the A-L interface, recapitulating key elements of tumors in the esophageal tube, i.e., direct contact with the gas phase and three-dimensional architecture. On the other hand, FLO-1 models exhibited high permeability to model drugs and zero permeability markers, and low transepithelial resistance, and therefore poorly mimicked normal esophageal epithelium. In conclusion, the identified effect of culture conditions on the characteristics of FLO-1 cells should be considered for standardization, data reproducibility and validity of the in vitro EAC model. Moreover, the sphere-forming ability of FLO-1 cells at the A-L interface should be considered in EAC tumor biology and anticancer drug studies as a reliable and straightforward model with the potential to increase the predictive efficiency of the current in vitro approaches.

摘要

FLO-1 细胞系是食管腺癌(EAC)研究中的一个重要工具,因为它是一种经过验证和真实的细胞系,可以用于研究疾病的病理生理学和抗肿瘤药物筛选。由于细胞的体外特性取决于微环境和培养条件,我们在不同的培养条件下对 FLO-1 细胞系进行了彻底的表征,目的是:(1)研究无血清生长培养基和气液界面(A-L)培养的影响,这更能反映体内的生理条件;(2)研究 FLO-1 细胞的分化潜力,以模拟体内食管上皮的特性。我们的研究表明,培养基的成分影响了 FLO-1 细胞的形态、超微结构和分子特征,如连接蛋白的表达。重要的是,FLO-1 细胞在 A-L 界面形成球体,再现了食管管内肿瘤的关键特征,即与气相直接接触和三维结构。另一方面,FLO-1 模型对模型药物和零通透性标记物表现出高通透性,对正常食管上皮的跨上皮电阻低,通透性差。总之,培养条件对 FLO-1 细胞特性的影响应在体外 EAC 模型的标准化、数据重现性和有效性方面得到考虑。此外,在 EAC 肿瘤生物学和抗癌药物研究中,应考虑 FLO-1 细胞在 A-L 界面形成球体的能力,因为它是一种可靠且简单的模型,有可能提高当前体外方法的预测效率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/6a20581fd5dd/41598_2021_85530_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/1156258c4e21/41598_2021_85530_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/1b41ea327303/41598_2021_85530_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/763c5562e7c4/41598_2021_85530_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/92a7a3c040fa/41598_2021_85530_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/3dcdf192bdea/41598_2021_85530_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/510125dca14c/41598_2021_85530_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/2303a7e9cca4/41598_2021_85530_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/f5fbf5f40ec0/41598_2021_85530_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/8ce563dbf2bc/41598_2021_85530_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/aacc790742d2/41598_2021_85530_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/cc340be92312/41598_2021_85530_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/6a20581fd5dd/41598_2021_85530_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/1156258c4e21/41598_2021_85530_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/1b41ea327303/41598_2021_85530_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/763c5562e7c4/41598_2021_85530_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/92a7a3c040fa/41598_2021_85530_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/3dcdf192bdea/41598_2021_85530_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/510125dca14c/41598_2021_85530_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/2303a7e9cca4/41598_2021_85530_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/f5fbf5f40ec0/41598_2021_85530_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/8ce563dbf2bc/41598_2021_85530_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/aacc790742d2/41598_2021_85530_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/cc340be92312/41598_2021_85530_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b0/7988140/6a20581fd5dd/41598_2021_85530_Fig12_HTML.jpg

相似文献

1
Standardization of esophageal adenocarcinoma in vitro model and its applicability for model drug testing.食管腺癌体外模型的标准化及其在模型药物测试中的适用性。
Sci Rep. 2021 Mar 23;11(1):6664. doi: 10.1038/s41598-021-85530-w.
2
Drug-induced expression of EpCAM contributes to therapy resistance in esophageal adenocarcinoma.药物诱导的 EpCAM 表达有助于食管腺癌的治疗抵抗。
Cell Oncol (Dordr). 2018 Dec;41(6):651-662. doi: 10.1007/s13402-018-0399-z. Epub 2018 Aug 16.
3
Statin therapy attenuates growth and malignant potential of human esophageal adenocarcinoma cells.他汀类药物治疗可减弱人食管腺癌细胞的生长和恶性潜能。
J Thorac Cardiovasc Surg. 2011 Nov;142(5):1152-60. doi: 10.1016/j.jtcvs.2011.08.004.
4
INHBA overexpression promotes cell proliferation and may be epigenetically regulated in esophageal adenocarcinoma.抑制素βA(INHBA)过表达促进细胞增殖,且在食管腺癌中可能受表观遗传调控。
J Thorac Oncol. 2009 Apr;4(4):455-62. doi: 10.1097/JTO.0b013e31819c791a.
5
Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis.源自FLO-1细胞的新型食管腺癌转移模型凸显了E-钙黏蛋白在癌症转移中的重要性。
Oncotarget. 2016 Dec 13;7(50):83342-83358. doi: 10.18632/oncotarget.13391.
6
Exploring Drug Dosing Regimens In Vitro Using Real-Time 3D Spheroid Tumor Growth Assays.利用实时 3D 球体肿瘤生长测定法探索体外药物剂量方案。
SLAS Discov. 2017 Jun;22(5):537-546. doi: 10.1177/2472555217698818. Epub 2017 Mar 15.
7
The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo.血管紧张素II 1型受体拮抗剂替米沙坦在体外和体内通过AMPKα/mTOR途径抑制食管腺癌的细胞增殖和肿瘤生长。
Oncotarget. 2017 Jan 31;8(5):8536-8549. doi: 10.18632/oncotarget.14345.
8
Signaling in H2O2-induced increase in cell proliferation in Barrett's esophageal adenocarcinoma cells.H2O2 诱导的巴雷特食管腺癌细胞增殖中的信号转导。
J Pharmacol Exp Ther. 2011 Oct;339(1):218-27. doi: 10.1124/jpet.111.182352. Epub 2011 Jul 12.
9
Identification and characterization of stemlike cells in human esophageal adenocarcinoma and normal epithelial cell lines.鉴定和鉴定人食管腺癌和正常上皮细胞系中的干细胞样细胞。
J Thorac Cardiovasc Surg. 2012 Nov;144(5):1192-9. doi: 10.1016/j.jtcvs.2012.08.008. Epub 2012 Sep 12.
10
MiR-145 expression accelerates esophageal adenocarcinoma progression by enhancing cell invasion and anoikis resistance.微小RNA-145的表达通过增强细胞侵袭和抗失巢凋亡能力促进食管腺癌进展。
PLoS One. 2014 Dec 31;9(12):e115589. doi: 10.1371/journal.pone.0115589. eCollection 2014.

引用本文的文献

1
Dr. Jekyll or Mr. Hyde: The multifaceted roles of miR-145-5p in human health and disease.杰基尔博士还是海德先生:miR-145-5p在人类健康与疾病中的多面角色。
Noncoding RNA Res. 2024 Nov 10;11:22-37. doi: 10.1016/j.ncrna.2024.11.001. eCollection 2025 Apr.
2
A High Throughput Screen with a Clonogenic Endpoint to Identify Radiation Modulators of Cancer.高通量筛选具有集落形成终点的方法以鉴定癌症的辐射调节剂。
Radiat Res. 2023 Feb 1;199(2):132-147. doi: 10.1667/RADE-22-00086.1.
3
Identification of novel interferon responsive protein partners of human leukocyte antigen A (HLA-A) using cross-linking mass spectrometry (CLMS) approach.

本文引用的文献

1
Role of Cadherins in Cancer-A Review.黏附素在癌症中的作用——综述。
Int J Mol Sci. 2020 Oct 15;21(20):7624. doi: 10.3390/ijms21207624.
2
RAD51 Inhibitor Reverses Etoposide-Induced Genomic Toxicity and Instability in Esophageal Adenocarcinoma Cells.RAD51抑制剂可逆转依托泊苷诱导的食管腺癌细胞基因组毒性和不稳定性。
Arch Clin Toxicol (Middlet). 2020;2(1):3-9. doi: 10.46439/toxicology.2.006.
3
Towards personalized induction therapy for esophageal adenocarcinoma: organoids derived from endoscopic biopsy recapitulate the pre-treatment tumor.
使用交联质谱(CLMS)方法鉴定人白细胞抗原 A(HLA-A)的新型干扰素反应蛋白伴侣。
Sci Rep. 2022 Nov 12;12(1):19422. doi: 10.1038/s41598-022-21393-z.
4
Barrett's Metaplasia Progression towards Esophageal Adenocarcinoma: An Attempt to Select a Panel of Molecular Sensors and to Reflect Clinical Alterations by Experimental Models.巴雷特食管化生向食管腺癌的进展:尝试选择一组分子传感器并通过实验模型反映临床变化。
Int J Mol Sci. 2022 Mar 18;23(6):3312. doi: 10.3390/ijms23063312.
针对食管腺癌的个体化诱导治疗:内镜活检衍生的类器官重现治疗前肿瘤。
Sci Rep. 2020 Sep 3;10(1):14514. doi: 10.1038/s41598-020-71589-4.
4
Ciliary beat frequency of in vitro human nasal epithelium measured with the simple high-speed microscopy is applicable for safety studies of nasal drug formulations.用简单高速显微镜测量体外人鼻上皮的纤毛摆动频率可用于鼻用药物制剂的安全性研究。
Toxicol In Vitro. 2020 Aug;66:104865. doi: 10.1016/j.tiv.2020.104865. Epub 2020 Apr 18.
5
Multifunctional Gas and pH Fluorescent Sensors Based on Cellulose Acetate Electrospun Fibers Decorated with Rhodamine B-Functionalised Core-Shell Ferrous Nanoparticles.基于纤维素乙酸酯电纺纤维的多功能气体和 pH 荧光传感器,其表面修饰有罗丹明 B 功能化核壳结构的亚铁纳米粒子。
Sci Rep. 2020 Jan 15;10(1):367. doi: 10.1038/s41598-019-57291-0.
6
Suitability of RPMI 2650 cell models for nasal drug permeability prediction.RPMI 2650 细胞模型用于鼻腔药物渗透预测的适用性。
Eur J Pharm Biopharm. 2019 Dec;145:85-95. doi: 10.1016/j.ejpb.2019.10.008. Epub 2019 Oct 19.
7
Targeting Cancer Cell Metastasis by Converting Cancer Cells into Fat.通过将癌细胞转化为脂肪来靶向癌症细胞转移。
Cancer Res. 2019 Nov 1;79(21):5471-5475. doi: 10.1158/0008-5472.CAN-19-1242. Epub 2019 Jul 22.
8
Demonstrating suitability of the Caco-2 cell model for BCS-based biowaiver according to the recent FDA and ICH harmonised guidelines.根据最近的 FDA 和 ICH 协调指导原则,证明 Caco-2 细胞模型适用于基于生物药剂分类系统的生物豁免。
J Pharm Pharmacol. 2019 Aug;71(8):1231-1242. doi: 10.1111/jphp.13111. Epub 2019 Jun 2.
9
Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer.靶向癌症干细胞:有效根除癌症的策略
Cancers (Basel). 2019 May 27;11(5):732. doi: 10.3390/cancers11050732.
10
EMT Transition States during Tumor Progression and Metastasis.肿瘤进展和转移过程中的 EMT 过渡态。
Trends Cell Biol. 2019 Mar;29(3):212-226. doi: 10.1016/j.tcb.2018.12.001. Epub 2018 Dec 26.